Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants.

Rathogwa, Ntungufhadzeni M; Scott, Katherine A; Opperman, Pamela; Theron, Jacques; Maree, Francois F

Rathogwa, Ntungufhadzeni M; Scott, Katherine A; Opperman, Pamela; Theron, Jacques; Maree, Francois F.

Afiliación

Rathogwa NM; Vaccines and Diagnostic Development, Onderstepoort Veterinary Research, Agricultural Research Council, Onderstepoort 0110, South Africa.
Scott KA; Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0002, South Africa.
Opperman P; Vaccines and Diagnostic Development, Onderstepoort Veterinary Research, Agricultural Research Council, Onderstepoort 0110, South Africa.
Theron J; Vaccines and Diagnostic Development, Onderstepoort Veterinary Research, Agricultural Research Council, Onderstepoort 0110, South Africa.
Maree FF; Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa.

Vaccines (Basel) ; 9(9)2021 Sep 07.

Article en En | MEDLINE | ID: mdl-34579233

Palabras clave

SAT2; adjuvant; foot-and-mouth disease virus; stabilized antigen; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google